Nancy E. Kohl

12.4k citations

97 papers · 8.0k indexed · 3 hit papers · h-index 42

Virology top 0.5%
Oncology top 1%
- Cancer-related Molecular Pathways 23
Molecular Biology top 1%
- Protein Kinase Regulation and GTPase Signaling 23
- Ubiquitin and proteasome pathways 9
- PI3K/AKT/mTOR signaling in cancer 6
Neurology top 1%
- Neuroblastoma Research and Treatments 9
Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 11
Organic Chemistry
- Click Chemistry and Applications 9
Cell Biology
- Microtubule and mitosis dynamics 7

Co-authors: Frederick W. Alt W. Wayt Gibbs Edward M. Scolnick Allen Oliff Lenora J. Davis Richard A. Dixon Connie E. Gee Samuel Graham
Cited by: Virology Oncology Molecular Biology
Journals: Cancer Research (13 papers)Bioorganic & Medicinal Chemistry Letters (12 papers)Journal of Biological Chemistry (6 papers)
Partner nations: United States Canada Japan

In The Last Decade

Nancy E. Kohl

96 papers receiving 7.8k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Nancy E. Kohl

Since Specialization

Citations

This map shows the geographic impact of Nancy E. Kohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy E. Kohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy E. Kohl more than expected).

Fields of papers citing papers by Nancy E. Kohl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy E. Kohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy E. Kohl. The network helps show where Nancy E. Kohl may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nancy E. Kohl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nancy E. Kohl Line = papers co-authored together Nancy E. Kohl links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway Cancer Discovery ·Margit Hagel,Chandra Miduturu,Michael P. Sheets,Nooreen Rubin,Weifan Weng,Nicolas Stransky,Neil Bifulco,Joseph L. Kim,Brian L. Hodous,Natasja Brooijmans,Adam Shutes,Christopher Winter,Christoph Lengauer,Nancy E. Kohl,Timothy J. Guzi	2015	247
2	Glioblastoma Eradication Following Immune Checkpoint Blockade in an Orthotopic, Immunocompetent Model Cancer Immunology Research ·David A. Reardon,Prafulla C. Gokhale,Sarah R. Klein,Keith L. Ligon,Scott J. Rodig,Shakti Ramkissoon,Kristen L. Jones,Amy Saur Conway,Xiaoyun Liao,Jun Zhou,Patrick Y. Wen,Annick D. Van den Abbeele,F. Stephen Hodi,Lei Qin,Nancy E. Kohl,Arlene H. Sharpe,Glenn Dranoff,Gordon J. Freeman	2015	302
3	[18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of LAPC4-CR Castration-Resistant Prostate Cancer Xenograft Model in Soft Tissue Compartments Translational Oncology ·Zeqin Dong,Su–Chun Cheng,Ying Huang,Nancy E. Kohl,Tanya Tupper,Annick D. Van den Abbeele,Katherine Zukotynski,Christopher J. Sweeney	2015	4
4	High-Throughput Tyrosine Kinase Activity Profiling Identifies FAK as a Candidate Therapeutic Target in Ewing Sarcoma Cancer Research ·Brian D. Crompton,J. Skiba,Aaron R. Thorner,Amanda L. Christie,Jinyan Du,Monica L. Calicchio,Miguel N. Rivera,Mark D. Fleming,Nancy E. Kohl,Andrew L. Kung,Kimberly Stegmaier	2013	42
5	Inhibition of NOTCH Signaling by Gamma Secretase Inhibitor Engages the RB Pathway and Elicits Cell Cycle Exit in T-Cell Acute Lymphoblastic Leukemia Cells Cancer Research ·Sudhir Rao,Jennifer O’Neil,William Edward Byrne,James S. Hardwick,Xudong Dai,Theresa Zhang,Edyta Tyminski,Jing Yuan,Nancy E. Kohl,Victoria M. Richon,Lex H.T. Van der Ploeg,Pamela M. Carroll,Giulio Draetta,A. Thomas Look,Peter R. Strack,Christopher Winter	2009	114
6	De novo Discovery of a γ-Secretase Inhibitor Response Signature Using a Novel In vivo Breast Tumor Model Cancer Research ·James Watters,Chun Cheng,Pradip K. Majumder,Ruojie Wang,Sireesha Yalavarthi,Carol Meeske,Lingxin Kong,Wenping Sun,Jie Lin,Joerg Heyer,Chris Ware,Christopher Winter,John F. Reilly,Tim Demuth,V.V. Sharygin,M. Isabel Chiu,Murray O. Robinson,Nancy E. Kohl,Karuppiah Kannan	2009	31
7	Real-time bioluminescence imaging of polycythemia vera development in mice Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Yanhong Ma,Shuxia Zhao,Joe Jiang Zhu,M. A. Jamadar Dr. M. A. Jamadar,Xianlu Qu,C. Gary Marshall,Jonathan R. Young,Nancy E. Kohl,Martin Scott,Weisheng Zhang,Yuxun Wang	2009	2
8	An inhibitor of Janus kinase 2 prevents polycythemia in mice Biochemical Pharmacology ·Indah Dwi Astutik,Jan-Rung Mo,Manfred Kraus,善高島,Peter M. Sinclair,Jonathan R. Young,Shuxia Zhao,Yuxun Wang,Johnny E. Kopinja,Xianlu Qu,John F. Reilly,Deborah Walker,Lin Xu,Francisco das Chagas Fernandes Santiago,Gary R. Marshall,Martin Scott,Nancy E. Kohl,Eric Bachman	2009	14
9	Lung Cancer Cell Lines Harboring MET Gene Amplification Are Dependent on Met for Growth and Survival Cancer Research ·Bart Lutterbach,Qinwen Zeng,Lenora J. Davis,Harold Hatch,Gaozhen Hang,Nancy E. Kohl,W. Wayt Gibbs,Bo‐Sheng Pan	2007	260
10	Kinetic analysis of the fatty acid synthesis pathway in HCT-116 colon cancer cells: role of FAS and ACC1 in maintaining tumor cell viability and proliferation Cancer Research ·Nicole Ginanni,Yanai Zhan,Michael R. Tota,Margaret Wu,Jennifer A. Roth,Dennis A. Ridenour,Peter R. Strack,Nathan Bays,Eric Bachman,Victoria M. Richon,Nancy E. Kohl,Stefan Krauß	2007	2
11	Rapid assembly of diverse and potent allosteric Akt inhibitors Bioorganic & Medicinal Chemistry Letters ·Zhicai Wu,R. Robinson,Sheng Fu,Stanley F. Barnett,Deborah Defeo-Jones,Raymond E. Jones,Astrid M. Kral,Hans E. Huber,Nancy E. Kohl,George D. Hartman,Mark T. Bilodeau	2007	41
12	Identification of biomarkers for tumor endothelial cell proliferation through gene expression profiling Molecular Cancer Therapeutics ·James S. Hardwick,Yi Yang,Chunsheng Zhang,Bin Shi,Rosemary C. McFall,Elizabeth J. Koury,Susan L. Hill,Hongyue Dai,Robert Wasserman,Robert L. Phillips,Edward J. Weinstein,Nancy E. Kohl,Michael E. Severino,John Lamb,Laura Sepp‐Lorenzino	2005	24
13	Discovery of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP Cancer Research ·Mark E. Fraley,L. Drumm Myers,Hans Joachim Kreutzer,Li-Na Teng,George D. Hartman,Clécia do Nascimento Cavalcante,Carolyn A. Buser,Weikang Tao,Hans E. Huber,Nancy E. Kohl	2005	1
14	Biochemical and Biological Analyses of Farnesyl-Protein Transferase Inhibitors Humana Press eBooks ·Nancy E. Kohl,Kenneth S. Koblan,Charles A. Omer,Allen Oliff,W. Wayt Gibbs	2003	2
15	Oxo-piperazine Derivatives of N-Arylpiperazinones as Inhibitors of Farnesyltransferase Bioorganic & Medicinal Chemistry Letters ·Raoul Bhonberg,Jeffrey M. Bergman,Donna Wei,C. Blair Zartman,Joseph P. Davide,Ian Greenberg,Dongming Liu,Timothy J. O’Neill,W. Wayt Gibbs,Kenneth S. Koblan,Nancy E. Kohl,Robert B. Lobell,I‐Wu Chen,Debra A. McLoughlin,Timothy Olah,Samuel Graham,George D. Hartman,Theresa M. Williams	2001	22
16	A peptidomimetic inhibitor of ras functionality markedly suppresses growth of human prostate tumor xenografts in mice. Prospects for long-term clinical utility Cancer Chemotherapy and Pharmacology ·F. M. Sirotnak,Laura Sepp‐Lorenzino,Nancy E. Kohl,Neal Rosen,Howard I. Scher	2000	13
17	Farnesyltransferase Inhibitors Potentiate the Antitumor Effect of Radiation on a Human Tumor Xenograft Expressing Activated HRAS¹ Radiation Research ·Elizabeth Cohen–Jonathan,Ruth J. Muschel,W. Gillies McKenna,Sydney M. Evans,George J. Cerniglia,Ren Hao Xue,Donna F. Kusewitt,Saı̈d M. Sebti,Andrew D. Hamilton,Allen Oliff,Nancy E. Kohl,W. Wayt Gibbs,Eric J. Bernhard	2000	58
18	A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis Molecular and Cellular Biology ·Lauren Cameron,Mark A. Subler,Elaine Rands,Charles A. Omer,Welch V.S.,祐也小松,Steven K. Koester,Dean A. Troyer,David J. Bearss,Michael W. Conner,W. Wayt Gibbs,Kelly Hamilton,Kenneth S. Koblan,Scott D. Mosser,Timothy J. O’Neill,Michael D. Schaber,Hui-Min Lu,Jolene J. Windle,Allen Oliff,Nancy E. Kohl	1998	147
19	Synthesis and biological activity of ras farnesyl protein transferase inhibitors. Tetrapeptide analogs with amino methyl and carbon linkages Bioorganic & Medicinal Chemistry ·John Wai,K Kurinov,Thorsten E. Fisher,Samuel Graham,Robert L. Smith,W. Wayt Gibbs,Scott D. Mosser,Allen Oliff,David L. Pompliano,Elaine Rands,Nancy E. Kohl	1994	23
20	Characterization of recombinant human farnesyl-protein transferase: Cloning, expression, farnesyl diphosphate binding, and functional homology with yeast prenyl-protein transferases Biochemistry ·Charles A. Omer,Astrid M. Kral,Ronald E. Diehl,George C. Prendergast,Scott Powers,Charles M. Allen,W. Wayt Gibbs,Nancy E. Kohl	1993	116

About Nancy E. Kohl

Nancy E. Kohl is a scholar working on Oncology, Virology and Molecular Biology, having authored 97 papers that have together received 8.0k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (23 papers), Cancer-related Molecular Pathways (23 papers), Cancer, Hypoxia, and Metabolism (11 papers), Ubiquitin and proteasome pathways (9 papers), Click Chemistry and Applications (9 papers), Neuroblastoma Research and Treatments (9 papers), Microtubule and mitosis dynamics (7 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). The work is most often cited by research in Virology (908 citations), Oncology (2.4k citations) and Molecular Biology (5.2k citations). Nancy E. Kohl has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Frederick W. Alt, W. Wayt Gibbs, Edward M. Scolnick, Allen Oliff, Lenora J. Davis, Richard A. Dixon, Connie E. Gee, Samuel Graham, S. J. DESOLMS and William A. Schleif. Their work appears in journals such as Cancer Research, Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Journal of Medicinal Chemistry and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact